Great find and thank you for posting ,,, These guys may want to...

Great find and thank you for posting ,,, These guys may want to check out the depth of Patents that PAA have in the Oncology field before progressing too much further,,, they may end up entering a minefield of IP infringement..
Joint Patent with Japanese Corporation now published

	IP exchange with UNSW consolidates MPL patent position

	New patent granted for non-cancer applications

	PharmAust secures core patent in Japan

New European patent granted for non-cancer applications
PharmAust secures core Europe patent
New patent secured in US for non-cancer applications
New drugs patented for cancer in USA

	New MPL analogues show greater anti-cancer activity

	PharmAust Intellectual Property Update

2016204389 MPL for Treatment of Cancer Granted Australia 10/05/2018
2868120 MPL for Treatment of Cancer Allowed Canada 9/11/2018
201610041111.6 MPL Analogues for Treatment of
Cancer Allowed China 28/01/2019
2817286 MPL for Treatment of Cancer Granted Europe 6/06/2018
16162192.5 MPL Analogues for Treatment of
Cancer Allowed Europe 22/11/2018
2017-36116 MPL Analogues for Treatment of
Cancer Allowed Japan 21/01/2019
HK1205502 Compounds for the treatment of
mTOR pathway related diseases Granted Hong Kong 20/04/2018
6441219 Compounds for the treatment of
mTOR pathway related diseases Granted Japan 30/11/2018
10,053,422
Compounds for the treatment of
mTOR pathway related diseases
with Analogues
Granted United States of
America 21/08/2018
14781682.1
Anticancer agent comprising
aminoacetonitrile compound as
active ingredient (MPL Analogues)
Allowed Europe 14/12/2018
9,907,778
Anticancer agent comprising
aminoacetonitrile compound as
active ingredient (MPL Analogues)
Granted United States of
America 6/03/2018
15/878057
Anticancer agent comprising
aminoacetonitrile compound as
active ingredient (MPL Analogues)
Allowed United States of
America 15/01/2019

There are more but it's coffee time ,